New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
09:18 EDTMDRX, DFS, JBL, ELOQ, ICE, BBBY, RAD, VVUS, NYX, FOLD, CAG, ORCLOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Rite Aid (RAD), up 17.3%... Jabil Circuit (JBL), up 5.4%... ConAgra (CAG), up 3.1%... ALSO HIGHER: NYSE Euronext (NYX), up 40.2% after acquisition by IntercontinentalExchange (ICE) for $33.12 per share in case and stock... Eloqua (ELOQ), up 30% after agreeing to be bought by Oracle (ORCL) for $23.50... VIVUS (VVUS), up 7.9% after Express Scripts (ESRX) adds Qsymia to formulary, takeover speculation fueled by Daily Mail report... LOWER AFTER EARNINGS: Bed Bath & Beyond (BBBY), down 5.8%... Discover (DFS), down 2.2%... ALSO LOWER: Amicus Therapeutics (FOLD), down 43.5% after drug doesn't show statistical benefit in study... Allscripts (MDRX), down 15.9% after evaluation of strategic alternatives ends without sale, CEO steps down.
News For NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD From The Last 14 Days
Check below for free stories on NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 10, 2014
14:44 EDTRADRite Aid trades at multi-year highs, levels to watch
The shares gapped up today and have remained in a tight range, last up over 10% to $7.05. At that price, next resistance is at the session high at $7.39 and then at $7.53. Support is at $6.95.
13:43 EDTICEFidelity to pitch new lost cost trading venue to large asset managers, WSJ says
Fidelity is working on a new trading venue, dubbed "Sakura," that it hopes will be a collaboration among big mutual-fund firms to reduce costs and streamline trading and will be an improvement over other "dark pools," reported The Wall Street Journal, citing people with knowledge of the matter. The report said Fidelity is in the initial planning stages and has just started pitching the idea to other large asset managers. Publicly traded fund managers include BlackRock (BLK), Franklin Resources (BEN) and T. Rowe Price (TROW), while Investment Technology Group (ITG) currently operates dark pools that facilitate block trading among large institutions. Exchange operators Nasdaq (NDAQ) and Intercontinentalexchange's (ICE) NYSE have previously testified to legislators that too much trading occurs in dark pools, hurting investors. Reference Link
12:25 EDTRAD, BBBYOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTRADRite Aid rises 10.3%
Subscribe for More Information
11:47 EDTBBBYBed Bath & Beyond approaches 52-week low after profit forecast disappoints
Subscribe for More Information
11:23 EDTRADRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
11:15 EDTBBBYOptions with decreasing implied volatility: YONG STZ BBBY FDO EPB
10:00 EDTBBBYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTRADRite Aid rises 11.2%
Rite Aid is up 11.2%, or 72c, to $7.12
09:37 EDTRADActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
09:21 EDTBBBY, RADOn The Fly: Pre-market Movers
Subscribe for More Information
09:06 EDTORCLOracle management to meet with Deutsche Bank
Subscribe for More Information
09:00 EDTBBBYBed Bath & Beyond falls 5%
Subscribe for More Information
09:00 EDTRADRite Aid rises 11.2%
Rite Aid is up 11.2%, or 72c, to $7.12
07:43 EDTBBBYBed Bath & Beyond price target lowered to $75 from $80 at Argus
Subscribe for More Information
07:15 EDTBBBYBed Bath & Beyond price target lowererd to $70 from $78 at Credit Suisse
Credit Suisse lowered Bed Bath & Beyond 's estimates due to slower than expected buybacks and a lower growth rated. Shares are Neutral rated.
07:06 EDTRADRite Aid sees FY15 EPS 31c-42c, consensus 35c
Subscribe for More Information
07:05 EDTRADRite Aid reports Q4 EPS 10c ex-items, consensus 4c
Subscribe for More Information
06:35 EDTRADRite Aid acquires RediClinic, details not disclosed
Rite Aid announced it has acquired Houston-based RediClinic. RediClinic currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Through the acquisition, RediClinic will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed.
05:49 EDTBBBYBed Bath & Beyond downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use